Well-intentioned financial guidance from previous generations often fails to account for today's economic realities. From home ownership to savings accounts, we examine the advice that hasn't aged well and what you should consider instead.
Amidst a challenging macro landscape, telecom operator VEON Ltd. is posting robust growth in its core frontier markets while aggressively expanding its digital ecosystem. With a valuation significantly below peers, analysts are debating whether the market is overlooking a hidden gem or rightly pricing in geopolitical risks.
Stryker Corporation's latest earnings report, driven by its MedSurg, Neurotechnology divisions and the Mako surgical robot, has reignited investor debate. With shares near $370 and a bullish fair value estimate of $427, analysts are weighing robust growth against a premium valuation.
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
Tetra Tech's stock has surged following strong Q1 results, raised guidance, and enhanced capital returns. While analysts see further upside, questions linger over contract risks and a premium valuation.
Oracle's deepening role as TikTok's U.S. data guardian and its aggressive push into regulated AI sectors present a dual narrative of strategic growth and heightened operational scrutiny, following a service outage linked to its infrastructure.
A wave of protests and student walkouts swept across the United States on Friday, demanding the withdrawal of federal immigration agents from Minnesota following fatal shootings, as political tensions threaten a government shutdown.
Former Federal Reserve Governor Kevin Warsh has been nominated by former President Donald Trump to chair the central bank, a move lauded by business leaders who cite his crisis-era experience and market savvy.
A dramatic sell-off in precious metals, led by a record-breaking drop in silver, rattled financial markets on January 30, 2026, as a surging U.S. dollar and shifting expectations for Federal Reserve policy triggered a broad retreat from risk assets.
Defense contractor L3Harris Technologies has been awarded a U.S. Navy contract to advance the Marine Corps' precision-strike capabilities with its long-range Red Wolf missile system, designed to counter maritime threats in the Pacific.
Singapore-listed construction firm Keong Hong Holdings reports a significant 42% rise in returns on capital employed over five years, signaling improved operational efficiency even as its asset base shrinks.
Social Security was designed as one component of a broader retirement strategy, not a standalone solution. For average earners, benefits typically replace about 40% of pre-retirement income, but experts urge personal savings to fill the gap.
Altria Group expects improved second-half earnings by leveraging a U.S. tobacco tax rebate tied to increased exports, as the Marlboro maker seeks new avenues for growth in a shrinking cigarette market.
Bernstein raises UPS price target to $128, citing robust fourth-quarter results that help balance a softer margin outlook. The logistics giant's strategic pivot away from low-margin Amazon business and ongoing cost-cutting measures shape its 2026 trajectory.
President Trump nominates former Fed governor Kevin Warsh to lead the central bank, setting the stage for a potential shift in monetary policy and a test of the institution's famed independence.
Bank of America has revised its price target for consumer goods giant Kimberly-Clark downward, citing sector-wide valuation pressures, even as the company reports resilient earnings and advances its transformation into a broader health and wellness player.
Buoyed by strategic brand exits and tariff mitigation, Church & Dwight enters 2026 with robust cash flow and a sharpened focus on its 'power brands' like Arm & Hammer and TheraBreath, despite a challenging consumer landscape.
High Tide Inc. reported record quarterly revenue and profitability in its fiscal Q4 2025, fueled by robust Canadian retail growth. The company outlined aggressive store expansion plans and detailed integration efforts for its new German medical cannabis asset, while also signaling cautious optimism regarding potential U.S. market entry.
Avidbank Holdings (AVBH) reported robust loan and deposit growth alongside an expanding net interest margin for Q4 2025, while management detailed plans to address a recent uptick in non-performing assets linked to specific construction and sponsor finance loans.
While fully autonomous robotic surgeons remain on the horizon, the foundational technology and data ecosystems being built today are setting the stage for a transformative shift. Two industry giants, Intuitive Surgical and Medtronic, offer investors distinct pathways to capitalize on this evolving landscape.
